Indian Sellers Collective, an umbrella body of trade associations and sellers across the country, has launched the Diwali Desi Delights campaign. The campaign champions Indian sweet items and savouries over western food items like chocolates and cakes. The campaign, which also aligns with Prime Minister
“Today, prevention is the cure!” Anu Acharya, CEO, Mapmygenome remarked at ABP Network’s The Southern Rising Summit 2024. In the session titled, “Knowing Yourself: Why it Matters”, Anu Acharya said, 'I started my journey 24 years ago in the domain of gene and genome, though I
New Development Targets Prevention of Severe Respiratory Syncytial Virus Infections The U.S. Food and Drug Administration (FDA) has granted approval for Pfizer's RSV vaccine, Abrysvo, aimed at preventing lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults aged 18 to 59 who are
This world class eye care facility has been built at an investment of around Rs 110-crore It will be super-specialty eye hospital spread over 1.26 lakh sq ft building The hospital will perform 30,000 free eye surgeries annually for economically weaker sections Will extend
This six-month initiative will be implemented in Mumbai, targeting Balwadis and primary-grade students aged between 3 and 14 years In a remarkable initiative aimed at fighting malnutrition among children, Akshaya Chaitanya, is proud to announce the launch of the “Bowl of Growth Program”. This program is
Fluoxetine Tabs 60 mg approval solidifies the Company's position in the molecule by complementing the recent approval in April 2024 for Fluoxetine 10 mg and 20 mg tablets and Fluoxetine capsules Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma
Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Limited, and includes its subsidiaries or associate companies) and Israel-based Moebius Medical Limited announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to MM-II (Large
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to market Scopolamine Transdermal System 1 mg/3 days. (USRLD: Transderm Scop Transdermal System ® 1 mg/3 days). This is the
Lupin Limited announced on Thursday the launch of its generic cancer treatment drug in the US market. The Mumbai-based pharmaceutical firm has introduced Doxorubicin Hydrochloride Liposome Injection in single-dose vials. This launch follows the approval from the US Food and Drug Administration (FDA) received by Lupin’s
ORSL® (औरसल), India’s #1 Electrolyte Drink, announced the launch of its new product line, Advanz Care. This innovative range offers three specialized variants designed to cater to a consumer’s diverse hydration, energy and immunity needs. As part of the portfolio of Advanz Care, ORSL® has launched
